Finland· FI-REL-REL52678
Ulipristal Acetate Gedeon Richter
A ulipristal product containing ulipristal acetate, registered in Finland by Gedeon Richter Plc. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ulipristal is registered in 5 of 19 countries.
Countries holding a registration under ATC G03XB02 (ulipristal), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 4 of them publish a price we can compare per daily dose
Ulipristal · ATC G03XB02
5 / 19 countries
- Belgiumprice
- Denmark
- Finlandprice
- Italyprice
- Polandprice
Price per daily dose
What a daily dose of ulipristal costs, country by country.
Normalised to the WHO defined daily dose (5 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ulipristal · price per daily dose (5 mg)
USD · FX 28 Sept 2026
- IT Italy$9.03
The record
At a glance
Fimea (Finland)- Active substance
- Ulipristal acetate
- Manufacturer
- Gedeon Richter Plc
- Country
- Finland (FI)
- ATC code
- G03XB02
- ATC class
- Ulipristal
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
98 interactions on record for ulipristal.
Graded by severity as the source publishes them — 2 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ulipristal · interactions on record
98 records
- 2 severe
- 77 moderate
- 19 minor
Most severe, free to view
- EdoxabanB01AF03severe
- VenetoclaxL01XX52severe
- NaldemedineA06AH05moderate
- RifaximinA07AA11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Ulipristal in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainESMYA 5 mg COMPRIMIDOSGedeon Richter Plc.
- United KingdomEsmya 5mg tabletsGedeon Richter (UK) Ltd
- PolandEsmyaGedeon Richter Plc.
- NetherlandsEcinq 30 mg filmomhulde tablettenAspen Healthcare Malta Limited
- GermanyFemkeExeltis Germany Gmbh
- BelgiumEllaOne 30 mgLaboratoire HRA Pharma
- CzechiaELLAONELaboratoire HRA Pharma, Chatillon
- FranceELLAONE 30 mg, comprimé pelliculéHRA PHARMA
Authorised across Europe · EMA
The same active substance is authorised in 18 EEA countries. Names it is sold under:
- Austria · Lencya, Ulipristal Acetate Hexal
- Czechia · Ulipristal Acetate Aristo
- Germany · Femke, Lencya
- Denmark · Femke, Ulipristal Acetate Stada
- Spain · Ulipristal Aristo, Ulipristal Aurovitas
- France · Ulipristal Acetate Biogaran, Ulipristal Acétate Exeltis
- United Kingdom (Northern Ireland) · Contrella, Ellaone
- Greece · Boled, Elperil
- Ireland · Ulipristal Acetate Rowex
- Iceland · Ellaone, Ulipristal Acetate Stada
- Italy · Evante, Lencya
- Liechtenstein · Ellaone
- Malta · Ecinq
- Netherlands · Ecinq, Evante
- Norway · Ellaone, Femke
- Poland · Misstala, Ulipristal Aristo
- Portugal · Femke, Ulipristal Aristo
- Sweden · Ulipristal Acetate Stada
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e7029172-9c9c-480e-bb5e-fab84d3c1fc2 GET /v1/drugs/e7029172-9c9c-480e-bb5e-fab84d3c1fc2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "5",
"form": "tabletti",
"route": null,
"ddd_unit": "mg",
"strength": "5 mg",
"atc_label": "ulipristaali",
"ma_number": null,
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": "EU/1/18/1309/01-05",
"fimea_rel_id": "REL52678",
"authorised_at": "2018-08-27"
}See everything about ulipristal.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.